ANTH : Insider Transactions for Anthera Pharmaceuticals Inc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Anthera Pharmaceuticals Inc (ANTH)

$0.00 0.00 (0.00%) as of 4:30 Tue 1/2

Download

Exchange:

Nasdaq Small Cap

Security Type:

Common

Shares Out:

11,447,000

Market Cap:

N/A

Last Volume:

23,616

Avg Vol:

0

52 Week Range:

$0.000001 - $0.008

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Drug Manufacturers - Major

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile Anthera Pharmaceuticals is a biopharmaceutical company focused on advancing the development and commercialization of medicines that benefit patients with medical needs. Co. has two compounds in development, Sollpura and blisibimod. Sollpura is a non-porcine investigational Pancreatic Enzyme Replacement Therapy intended for the treatment of patients with Exocrine Pancreatic Insufficiency, often seen in patients with cystic fibrosis and other conditions. Blisibimod targets B-cell activating factor, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	0	0	0	0
Total Sell Value	$0	$0	$0	$0
Total People Sold	0	0	0	0
Total Sell Transactions	0	0	0	0
End Date	2024-03-07	2023-12-05	2023-06-06	2022-06-06

Adjust Filter Settings

Records found: 221

Page 5 of 9

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Director

– • –

2011-12-13

4

S

$6.50

$105,300

I/I

(16,200)

2,831,800

-

Director

– • –

2011-12-09

4

S

$6.75

$270,000

I/I

(40,000)

2,848,000

-

Director

– • •

2011-11-18

4

S

$6.50

$19,500

I/I

(3,000)

2,888,000

-

Director

– • •

2011-11-17

4

S

$6.67

$160,080

I/I

(24,000)

2,891,000

-

Director

– • •

2011-11-16

4

S

$6.87

$171,750

I/I

(25,000)

2,915,000

-

President and CEO

• • –

2011-11-15

4

AS

$6.96

$208,704

I/I

(30,000)

657,125

-

President and CEO

• • –

2011-11-15

4

GA

$0.00

$0

I/I

50,000

687,125

-

President and CEO

• • –

2011-11-15

4

GD

$0.00

$0

D/D

50,000

40,512

-

Director

– • •

2011-11-15

4

S

$6.93

$346,500

I/I

(50,000)

2,940,000

-

Director

– • •

2011-11-14

4

S

$6.95

$34,750

I/I

(5,000)

2,990,000

-

Director

– • •

2011-11-11

4

S

$7.14

$35,700

I/I

(5,000)

2,995,000

-

Chief Medical Officer

• – –

2011-11-08

4

S

$6.74

$101,163

D/D

(15,000)

57,967

-

Chief Medical Officer

• – –

2011-11-08

4

OE

$0.26

$3,900

D/D

15,000

72,967

-

Thompson David E.

Director

– • –

2011-11-07

4

GD

$0.00

$0

I/I

3,800

7,758

-

Lowe Christopher P.

Chief Financial Officer & CBO

• – –

2011-11-03

4

AS

$6.88

$103,236

D/D

(15,000)

46,151

-

Lowe Christopher P.

Chief Financial Officer & CBO

• – –

2011-10-25

4

AS

$7.07

$32,784

I/I

(4,637)

0

-

President and CEO

• • –

2011-10-21

4

AS

$6.25

$145,219

I/I

(23,235)

637,125

-

President and CEO

• • –

2011-10-18

4

AS

$6.25

$42,156

I/I

(6,745)

660,360

-

Lowe Christopher P.

Chief Financial Officer & CBO

• – –

2011-08-08

4

OE

$1.34

$13,400

D/D

10,000

61,151

-

President and CEO

• • –

2011-08-08

4

OE

$0.26

$13,000

D/D

50,000

90,512

-

Lowe Christopher P.

Chief Financial Officer & CBO

• – –

2011-08-03

4

AS

$6.88

$100,432

D/D

(14,600)

51,151

-

Lowe Christopher P.

Chief Financial Officer & CBO

• – –

2011-08-02

4

AS

$7.28

$36,571

I/I

(5,000)

4,637

-

President and CEO

• • –

2011-07-15

4

AS

$7.95

$119,258

I/I

(15,000)

667,125

-

Chief Medical Officer

• – –

2011-07-12

4

OE

$0.26

$3,900

D/D

15,000

57,967

-

10% Owner

– – •

2011-07-07

4

OE

$1.34

$47,264

D/D

19,563

5,357,528

-

221 Records found	1 2 3 4 5 6 7 8 9	Page 5 of 9

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.